The genome sequence provides a blueprint, but epigenetics determines how that blueprint is read. Chemical modifications to DNA and histone proteins—without altering the underlying sequence—regulate which genes are expressed, when, and in which cell types. Epigenomics services that enable systematic profiling of these modifications are becoming central to disease research, particularly in oncology, neuroscience, and the study of complex multifactorial conditions.

What epigenomics measures

Epigenomic profiling encompasses a range of molecular assays targeting different layers of epigenetic regulation. DNA methylation—the addition of methyl groups to cytosine residues—is one of the most studied epigenetic marks and plays a central role in gene silencing, imprinting, and X-chromosome inactivation. Histone modification profiling through ChIP-seq or CUT&RUN reveals how chromatin accessibility and transcriptional activity are regulated across the genome. ATAC-seq identifies open chromatin regions associated with active regulatory elements. Together, these approaches provide a layered view of how the epigenome shapes gene expression programs in health and disease.

Epigenetic alterations in cancer

Cancer biology offers some of the clearest illustrations of epigenetic dysregulation. Aberrant DNA methylation—including hypermethylation of tumor suppressor gene promoters and global hypomethylation—is a hallmark of most cancer types. Histone modification patterns are also frequently disrupted, altering chromatin states in ways that support oncogenic gene expression programs. Epigenomics services that characterize these alterations can help identify disease-specific biomarkers, stratify patient populations, and reveal therapeutic vulnerabilities in chromatin regulatory pathways that are increasingly the target of epigenetic drugs.

Developmental biology and cell identity

Epigenetic regulation is central to how a single genome gives rise to hundreds of distinct cell types during development. Profiling the epigenome across developmental stages or across differentiated cell populations reveals the regulatory logic underlying cell identity—information that is critical for stem cell biology, organoid research, and understanding how cell fate decisions go awry in disease. Single-cell epigenomics approaches extend this resolution to the individual cell level, enabling researchers to characterize epigenetic heterogeneity within complex tissues and developmental trajectories.

Environmental exposures and epigenetic change

Unlike the genome sequence, the epigenome is dynamic and responsive to environmental inputs. Diet, stress, toxin exposure, and other environmental factors can alter methylation and chromatin states in ways that persist across cell divisions and, in some cases, across generations. Epidemiological epigenomics studies—often using methylation arrays or whole-genome bisulfite sequencing—are characterizing how environmental exposures leave molecular marks that may influence disease risk long after the exposure itself. These findings have implications for public health, personalized medicine, and our understanding of disease etiology.

Integrating epigenomics with other data modalities

Epigenomic data is most interpretable when integrated with complementary data types. Pairing methylation or chromatin accessibility profiles with RNA-seq data allows researchers to connect regulatory state with transcriptional output. Integration with genetic variant data links sequence differences with epigenetic effects, supporting the identification of regulatory variants underlying complex trait associations from genome-wide studies. Multiomics integration frameworks designed to handle heterogeneous data types are increasingly central to how epigenomics findings are contextualized and translated into mechanistic understanding.

Conclusion

Epigenomics services are enabling researchers to look beyond the genome sequence and into the regulatory architecture that controls it. As epigenetic mechanisms are increasingly recognized as drivers of disease, development, and environmental response, the ability to profile these marks systematically—and integrate them with other biological data—is becoming an essential capability for research programs seeking a complete view of molecular biology in health and disease.